Intervention Protocol

You have free access to this content

Prosthetic mesh placement for the prevention of parastomal herniation

  1. Michael Rees1,*,
  2. Huw Jones1,
  3. James Cragg2,
  4. Peter Billings3,
  5. Palanichamy Chandran3

Editorial Group: Cochrane Colorectal Cancer Group

Published Online: 1 DEC 2013

DOI: 10.1002/14651858.CD008905.pub2

How to Cite

Rees M, Jones H, Cragg J, Billings P, Chandran P. Prosthetic mesh placement for the prevention of parastomal herniation (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 12. Art. No.: CD008905. DOI: 10.1002/14651858.CD008905.pub2.

Author Information

  1. 1

    Wrexham Maelor Hospital, BCUHB, ST3 General Surgery, Wrexham, UK

  2. 2

    Wrexham Maelor Hospital, BCUHB, CT2 General Surgery, Wrexham, UK

  3. 3

    Wrexham Maelor Hospital, BCUHB, Department of General Surgery, Wrexham, Wales, UK

*Michael Rees, ST3 General Surgery, Wrexham Maelor Hospital, BCUHB, Croesnewydd Rd, Wrexham, LL13 7TD, UK.

Publication History

  1. Publication Status: Amended to reflect a change in scope (see 'What's new')
  2. Published Online: 1 DEC 2013




  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The overall objective of this review is to evaluate whether mesh reinforcement of abdominal wall stomas affects the incidence of parastomal herniation without affecting mortality. More specific objectives for review include the following.

  • Is mesh placement more effective in preventing parastomal herniation for certain stoma types (e.g. end vs loop, ileostomy vs colostomy)?
  • Does mesh placement affect the incidence of surgical intervention for adverse symptoms related to parastomal hernia formation?
  • Does mesh placement have an effect on total operative time or length of hospital stay?
  • What is the incidence of mesh-specific complications (i.e. stoma aperture stenosis/stricture, intestinal fistulation, mesh-related infection (with/without reoperation) and mortality)?
  • Does mesh placement have an influence on patient-reported symptoms and postoperative quality of life (i.e. difficulty with bag application, leakage of stoma bag contents, nausea, vomiting, abdominal bloating and parastomal discomfort)?
  • What is the impact of the intervention on rehospitalisation/ambulatory visits required for parastomal hernia problems/treatment?